FGF-23 is a biomarker of RV dysfunction and congestion in patients with HFrEF

被引：0
|
作者：
Benes, J. Jan [1 ]
Kroupova, K. [1 ]
Kotrc, M. [1 ]
Petrak, J. [2 ]
Jarolim, P. [3 ,4 ]
Novosadova, V. [5 ]
Kautzner, J. [1 ]
Melenovsky, V. [1 ]
机构：
[1] Inst Clin & Expt Med IKEM, Prague, Czech Republic
[2] Charles Univ Prague, Fac Med 1, BIOCEV, Vestec, Czech Republic
[3] Brigham & Womens Hosp, Dept Pathol, Boston, MA USA
[4] TIMI Grp, Boston, MA USA
[5] Acad Sci Czech Republ, Inst Mol Genet, Prague, Czech Republic
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2023年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：142 / 142
页数：1
相关论文
共 50 条
  • [1] FGF-23 is a biomarker of RV dysfunction and congestion in patients with HFrEF
    Jan Benes
    Katerina Kroupova
    Martin Kotrc
    Jiri Petrak
    Petr Jarolim
    Vendula Novosadova
    Josef Kautzner
    Vojtech Melenovsky
    Scientific Reports, 13
  • [2] FGF-23 is a biomarker of RV dysfunction and congestion in patients with HFrEF
    Benes, Jan
    Kroupova, Katerina
    Kotrc, Martin
    Petrak, Jiri
    Jarolim, Petr
    Novosadova, Vendula
    Kautzner, Josef
    Melenovsky, Vojtech
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [3] An Overview of FGF-23 as a Novel Candidate Biomarker of Cardiovascular Risk
    Vazquez-Sanchez, Sara
    Poveda, Jonay
    Navarro-Garcia, Jose Alberto
    Gonzalez-Lafuente, Laura
    Rodriguez-Sanchez, Elena
    Ruilope, Luis M.
    Ruiz-Hurtado, Gema
    FRONTIERS IN PHYSIOLOGY, 2021, 12
  • [4] Phosphate and FGF-23
    Jueppner, Harald
    KIDNEY INTERNATIONAL, 2011, 79 : S24 - S27
  • [5] FGF-23 and cognitive performance in hemodialysis patients
    Drew, David A.
    Tighiouart, Hocine
    Scott, Tammy M.
    Lou, Kristina V.
    Fan, Li
    Shaffi, Kamran
    Weiner, Daniel E.
    Sarnak, Mark J.
    HEMODIALYSIS INTERNATIONAL, 2014, 18 (01) : 78 - 86
  • [6] Clinical Significance of FGF-23 in Patients with CKD
    Russo, Domenico k
    Battaglia, Yuri
    INTERNATIONAL JOURNAL OF NEPHROLOGY, 2011, 2011
  • [7] Is FGF-23 an early indicator o atherosclerosis and cardiac dysfunction in patients with gestational diabetes?
    Tuzun, Dilek
    Oguz, Ayten
    Aydin, Muhammet Naci
    Kurutas, Ergul Belge
    Ercan, Onder
    Sahin, Murat
    Unsal, Veld
    Ceren, Imran
    Akcay, Ahmet
    Gul, Kamile
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2018, 62 (05): : 506 - 513
  • [8] FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease
    Yilmaz, Mahmut I.
    Sonmez, Alper
    Saglam, Mutlu
    Yaman, Halil
    Kilic, Selim
    Demirkaya, Erkan
    Eyileten, Tayfun
    Caglar, Kayser
    Oguz, Yusuf
    Vural, Abdulgaffar
    Yenicesu, Mujdat
    Zoccali, Carmine
    KIDNEY INTERNATIONAL, 2010, 78 (07) : 679 - 685
  • [9] FGF-23 in bone biology
    Wesseling-Perry, Katherine
    PEDIATRIC NEPHROLOGY, 2010, 25 (04) : 603 - 608
  • [10] FGF-23 in bone biology
    Katherine Wesseling-Perry
    Pediatric Nephrology, 2010, 25 : 603 - 608
12345